Yaotian Chang

2699 Qianjin Street
Changchun, 130012, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Broadly neutralizing antibodies against HIV-1 pseudoviruses elicited by envelope trimer DNA with chimeric design delivered via silica-calcium phosphate nanoparticles.

Broadly neutralizing antibodies against HIV-1 pseudoviruses elicited by envelope trimer DNA with chimeric design delivered via silica-calcium phosphate nanoparticles.

Journal: Nanoscale

Published: July 01, 2026

Self-assembling ferritin nanoparticles displaying glycoprotein B epitopes induce robust humoral and mucosal immunity against feline herpesvirus 1.

Self-assembling ferritin nanoparticles displaying glycoprotein B epitopes induce robust humoral and mucosal immunity against feline herpesvirus 1.

Journal: International journal of biological macromolecules

Published: February 14, 2026

Optimization of the monoclonal antibody 3E1 through W32I mutation enhances antiviral efficacy against influenza virus subtypes H1N1 and H3N2.

Optimization of the monoclonal antibody 3E1 through W32I mutation enhances antiviral efficacy against influenza virus subtypes H1N1 and H3N2.

Journal: Antiviral research

Published: June 28, 2025

Induction of enhanced stem-directed neutralizing antibodies by HA2-16 ferritin nanoparticles with H3 influenza virus boost.

Induction of enhanced stem-directed neutralizing antibodies by HA2-16 ferritin nanoparticles with H3 influenza virus boost.

Journal: Nanoscale advances

Published: November 20, 2024

Self-adjuvant multiepitope nanovaccine based on ferritin induced long-lasting and effective mucosal immunity against H3N2 and H1N1 viruses in mice.

Self-adjuvant multiepitope nanovaccine based on ferritin induced long-lasting and effective mucosal immunity against H3N2 and H1N1 viruses in mice.

Journal: International journal of biological macromolecules

Published: December 11, 2023

Self-Assembled Multiepitope Nanovaccine Provides Long-Lasting Cross-Protection against Influenza Virus.

Self-Assembled Multiepitope Nanovaccine Provides Long-Lasting Cross-Protection against Influenza Virus.

Journal: Advanced healthcare materials

Published: October 16, 2023

Improvement of B Cell Responses by an HIV-1 Amphiphilic Polymer Nanovaccine.

Improvement of B Cell Responses by an HIV-1 Amphiphilic Polymer Nanovaccine.

Journal: Nano letters

Published: April 30, 2023

Combined Nano-Vector Mediated-Transfer to Suppress HIV-1 Infection with Targeted Antibodies in-vitro.

Combined Nano-Vector Mediated-Transfer to Suppress HIV-1 Infection with Targeted Antibodies in-vitro.

Journal: International journal of nanomedicine

Published: April 06, 2023

Self-assembled multiepitope nanovaccine based on NoV P particles induces effective and lasting protection against H3N2 influenza virus.

Self-assembled multiepitope nanovaccine based on NoV P particles induces effective and lasting protection against H3N2 influenza virus.

Journal: Nano research

Published: October 26, 2022

Hemagglutinin-based DNA vaccines containing trimeric self-assembling nanoparticles confer protection against influenza.

Hemagglutinin-based DNA vaccines containing trimeric self-assembling nanoparticles confer protection against influenza.

Journal: Journal of leukocyte biology

Published: January 04, 2021

Showing 1-10 of 10

Last Updated: 09/26/2026